The Food and Drug Administration has approved Zoryve (roflumilast) topical foam, 0.3% for plaque psoriasis of the scalp and body.

About 1 in 3 people with psoriasis who achieved clear skin with biologic drugs still had underlying inflammation that may contribute to conditions like obesity and heart disease, a new study suggests.

“Interesting, the main thing that is often perceived as dandruff is caused by not washing the hair sufficiently or frequently ...

“Interesting, the main thing that is often perceived as dandruff is caused by not washing the hair sufficiently or frequently ...

Dr. Sharda Ayurveda has achieved a remarkable approach towards Psoriasis management with Ayurveda. According to Dr. Mukesh Sharda, it is a serious disease that can impact any generation. A sedentary ...

A new King’s College London study links abdominal fat—not general obesity—to increased psoriasis risk, especially in women, ...

Scalp to shins relief with expert tips - Itching to know what’s causing that scratch? Learn how hydration, barrier repair, ...

Symptoms, lesion locations, and morphology are among the features clinicians may use to distinguish hand eczema from hand psoriasis in patients.

The U.S. Food and Drug Administration has approved Arcutis Biotherapeutics' Zoryve (roflumilast) topical foam 0.3% for the ...

Omni Medique is a specialist regenerative hair and scalp clinic providing non-surgical hair restoration and scalp treatment ...

BELLY fat increases your risk of the skin condition psoriasis, a study warns. Psoriasis, which affects one in 50 people – ...

Hair loss is more common than you think. Here, we unpack the most common causes of hair loss and possible prevention tips ...